These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6507105)

  • 1. Active and passive immunization against Rift Valley fever virus infection in Syrian hamsters.
    Niklasson BS; Meadors GF; Peters CJ
    Acta Pathol Microbiol Immunol Scand C; 1984 Aug; 92(4):197-200. PubMed ID: 6507105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of a mutagen-attenuated Rift Valley fever virus vaccine in fetal and neonatal bovids.
    Morrill JC; Mebus CA; Peters CJ
    Am J Vet Res; 1997 Oct; 58(10):1110-4. PubMed ID: 9328663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and immunogenicity of recombinant Rift Valley fever MP-12 vaccine candidates in sheep.
    Morrill JC; Laughlin RC; Lokugamage N; Pugh R; Sbrana E; Weise WJ; Adams LG; Makino S; Peters CJ
    Vaccine; 2013 Jan; 31(3):559-65. PubMed ID: 23153443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental infection and protection of lambs with a minute plaque variant of Rift Valley fever virus.
    Moussa MI; Abdel-Wahab KS; Wood OL
    Am J Trop Med Hyg; 1986 May; 35(3):660-2. PubMed ID: 3706629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a formalin-inactivated Rift Valley fever vaccine in sheep.
    Harrington DG; Lupton HW; Crabbs CL; Peters CJ; Reynolds JA; Slone TW
    Am J Vet Res; 1980 Oct; 41(10):1559-64. PubMed ID: 7224281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity and safety of an inactivated Rift Valley fever vaccine in a 19-year study.
    Rusnak JM; Gibbs P; Boudreau E; Clizbe DP; Pittman P
    Vaccine; 2011 Apr; 29(17):3222-9. PubMed ID: 21354483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of a mutagen-attenuated Rift Valley fever virus vaccine in cattle.
    Morrill JC; Mebus CA; Peters CJ
    Am J Vet Res; 1997 Oct; 58(10):1104-9. PubMed ID: 9328662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-dose immunization with virus replicon particles confers rapid robust protection against Rift Valley fever virus challenge.
    Dodd KA; Bird BH; Metcalfe MG; Nichol ST; Albariño CG
    J Virol; 2012 Apr; 86(8):4204-12. PubMed ID: 22345465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection of MP-12-vaccinated rhesus macaques against parenteral and aerosol challenge with virulent rift valley fever virus.
    Morrill JC; Peters CJ
    J Infect Dis; 2011 Jul; 204(2):229-36. PubMed ID: 21673033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of a Rift Valley fever virus vaccine against an aerosol infection in rats.
    Anderson GW; Lee JO; Anderson AO; Powell N; Mangiafico JA; Meadors G
    Vaccine; 1991 Oct; 9(10):710-4. PubMed ID: 1759489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylaxis of Rift Valley fever with antiviral drugs, immune serum, an interferon inducer, and a macrophage activator.
    Peters CJ; Reynolds JA; Slone TW; Jones DE; Stephen EL
    Antiviral Res; 1986 Aug; 6(5):285-97. PubMed ID: 2429616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of Rift Valley fever Smithburn and Clone 13 vaccines in calves.
    von Teichman B; Engelbrecht A; Zulu G; Dungu B; Pardini A; Bouloy M
    Vaccine; 2011 Aug; 29(34):5771-7. PubMed ID: 21664400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ingestion of immune bloodmeals and infection of Aedes fowleri, Aedes mcintoshi, and Culex pipiens with Rift Valley fever virus.
    Patrican LA; Bailey CL
    Am J Trop Med Hyg; 1989 May; 40(5):534-40. PubMed ID: 2729509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study on DNA immune of envelope protein gene of Rift Valley Fever Virus].
    Wang QH; Wang XJ; Hu S; Ge JY; Bu ZG
    Wei Sheng Wu Xue Bao; 2007 Aug; 47(4):677-81. PubMed ID: 17944371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-cycle replicable Rift Valley fever virus mutants as safe vaccine candidates.
    Terasaki K; Tercero BR; Makino S
    Virus Res; 2016 May; 216():55-65. PubMed ID: 26022573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the efficacy and safety of the Rift Valley Fever Clone 13 vaccine in sheep.
    Dungu B; Louw I; Lubisi A; Hunter P; von Teichman BF; Bouloy M
    Vaccine; 2010 Jun; 28(29):4581-7. PubMed ID: 20470792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further evaluation of a mutagen-attenuated Rift Valley fever vaccine in sheep.
    Morrill JC; Carpenter L; Taylor D; Ramsburg HH; Quance J; Peters CJ
    Vaccine; 1991 Jan; 9(1):35-41. PubMed ID: 2008798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An inactivated rift valley fever vaccine.
    Barnard BJ; Botha MJ
    J S Afr Vet Assoc; 1977 Mar; 48(1):45-8. PubMed ID: 874947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against Rift Valley fever virus infection in mice upon administration of interferon-inducing RNA transcripts from the FMDV genome.
    Lorenzo G; Rodríguez-Pulido M; López-Gil E; Sobrino F; Borrego B; Sáiz M; Brun A
    Antiviral Res; 2014 Sep; 109():64-7. PubMed ID: 24973761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rift Valley fever virus infection in golden Syrian hamsters.
    Scharton D; Van Wettere AJ; Bailey KW; Vest Z; Westover JB; Siddharthan V; Gowen BB
    PLoS One; 2015; 10(1):e0116722. PubMed ID: 25607955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.